Previous Article | Next Article 
Infect Immun, August 1998, p. 3974-3977, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Use of Monoclonal Antibodies To Identify
Phospholipase C as the Enterotoxic Factor of the Bifunctional
Hemolysin-Phospholipase C Molecule of Vibrio cholerae
O139
Sangita
Pal,
Archana
Datta,*
G. Balakrish
Nair, and
Bhakti
Guhathakurta
National Institute of Cholera and Enteric
Diseases, Calcutta, India
Received 26 February 1998/Returned for modification 3 April
1998/Accepted 8 May 1998
 |
ABSTRACT |
Two hybrid clones producing monoclonal antibodies (MAbs) raised
against the purified enterotoxic hemolysin-phospholipase C (HlyPC)
bifunctional molecule of a Vibrio cholerae O139 strain were
used to study its enterotoxicity in relation to its hemolytic and
enzymatic activities. Fab fragments of MAbs from ascites
produced by the two hybrids neutralized the hemolytic activity of
HlyPC, leaving the enzymatic activity unaffected. In ligated rabbit
ileal loop and infant mouse intestine, the Fab fragments of the MAbs were not able to neutralize the enterotoxicity of HlyPC,
suggesting that PC rather than Hly is the enterotoxic moiety of
the molecule. The enterotoxicity of the purified PC molecule
isolated from an Hly
spontaneous mutant of the
HlyPC-producing parent strain further confirms this contention. The
Hly molecule isolated from a PC
mutant was not
diarrheagenic.
 |
TEXT |
Vibrio cholerae organisms
belonging to serogroups O1 and O139 are the causative agents of
epidemics of the disease cholera. The massive diarrhea produced
during the disease is attributed to the cholera enterotoxin (CT).
Deletion mutants of V. cholerae O1 strains deficient in
production of the CT molecule or its subunits, A and B, however, still
have been shown to induce mild to moderate diarrhea in volunteers
(12). The search for a cause of the diarrhea due to these
strains resulted in the discovery of additional toxins of V. cholerae O1, such as hemolysin-cytolysin, zonula occludens toxin,
and accessory cholera enterotoxin, etc., which have secretogenic effects on the intestinal mucosa (9). V. cholerae
is known to produce several hemolysins; the best studied among them,
the El Tor hemolysin, an hlyA gene product, has been
purified, characterized, and suggested to be a virulence factor
contributing to cholera pathogenesis (7, 14, 16). Clinical
isolates of V. cholerae non-O1 are also known to produce
a thermolabile hemolysin which is biologically, physicochemically, and
antigenically similar to El Tor hemolysin and is capable of inducing
fluid accumulation in ligated intestinal loops of adult rabbits
(8).
Recently, we purified and characterized a hemolysin from a V. cholerae O139 strain which also showed high phospholipase C activity (15). Association of phospholipase C enzymatic
activity with the V. cholerae hemolysin molecule had not
been indicated previously. The bifunctional
hemolysin-phospholipase C (HlyPC) molecule of V. cholerae O139
free from CT and of molecular mass of 67 kDa and pI 6.4
showed enterotoxic activity, as evidenced by fluid accumulation in
the ligated rabbit ileal loop and in the intestines of suckling mice.
The objective of the present study was to raise monoclonal antibodies
(MAbs) against the purified bifunctional HlyPC molecule of V. cholerae O139 and to use them to study the interrelationship of
the hemolytic and enzymatic activities of the HlyPC molecule
vis-à-vis its enterotoxic property.
HlyPC was purified from strain CO55/5, a clinical isolate of V. cholerae O139 which had undergone four serial passages in ligated
rabbit intestinal loops (15) to increase its hemolysin production. Spontaneous mutants of CO55/5, deficient in either hemolytic (Hly
) or phospholipase C (PC
)
activity, were selected by screening of single colonies of
CO55/5. The hemolytic activity of the culture supernatant was assayed according to the method of Tikoo et al. (19) with a 2%
rabbit erythrocyte suspension followed by spectrophotometric
measurement of the released hemoglobin at 540 nm. To isolate
PC
mutants of CO55/5, the phospholipase C activity
was monitored according to the spectrophotometric method of Berka
and Vasil (3) with the specific substrate
p-nitrophenyl phosphoryl choline.
HlyPC, Hly, and PC were purified from CO55/5 and its PC
and Hly
mutants, respectively, by Biogel P-100
chromatography of the ammonium sulfate precipitate of the culture
supernatant of the respective strains, followed by chromatofocusing on
a PBE 94 (Pharmacia) column, as detailed previously (15).
Figure 1 represents the purification of
PC. HlyPC and Hly were similarly purified, but separate representative
data are not shown.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
Purification of PC from Hly mutant of
CO55/5. (A) Fractionation of ammonium sulfate precipitate of culture
supernatant on Biogel P-100 regular column previously equilibrated and
eluted with Tris-EDTA-azide buffer, pH 8. , absorbance at 280 nm;
, PC activity of each fraction. (B) Chromatofocusing of Biogel P-100
column eluate of V. cholerae O139 phospholipase C on a PBE
94 column with 0.0025 M imidazole-HCl (pH 7.4) as start buffer and
polybuffer 74-HCl (pH 4.0) as eluent. , pH; , optical density
(O.D.) at 280 nm; , PC activity.
|
|
Antibodies.
Two stable hybrids, 3H7 and 4C1, were raised
by fusion of spleen cells of HlyPC-immunized BALB/c mice with
hypoxanthine-guanine phosphoribosyl transferase-deficient mouse myeloma
cells (P3 × 63; Ag 8.653) by standard procedures; ascites were
induced as previously described (18). Polyclonal antibodies
against HlyPC were raised in rabbits (15).
SDS-PAGE and immunoblotting.
The three purified
proteins, HlyPC, Hly, and PC, moved as 67-kDa molecules in sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10) (Fig.
2A) and reacted as well-defined similar single bands with polyclonal anti-HlyPC rabbit sera in immunoblotting by standard methods (21). The monoclonal ascitic fluids 3H7 and 4C1 reacted with HlyPC and Hly proteins but did not identify the PC
protein in the immunoblot (Fig. 2B).

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 2.
(A) SDS-PAGE of purified HlyPC, Hly, and PC in the
absence of mercaptoethanol. Lane 1, molecular mass marker; lane 2, HlyPC; lane 3, Hly; lane 4, PC. (B) Immunoblot after SDS-PAGE. Lane C,
Crude HlyPC (ammonium sulfate precipitate); lane 1, HlyPC; lane 2, Hly;
Lane 3, PC. a, developed with polyclonal anti-HlyPC serum; b, developed
with MAb 3H7 ascitic fluid.
|
|
Hemolytic, enzymatic, and enterotoxic activities of purified
Hly-PC, Hly, and PC in the presence of Fab fragments.
The
hemolytic activities of Hly and HlyPC were effectively inhibited by
treatment with Fab fragments of both the MAbs and the polyclonal
anti-HlyPC rabbit sera (Fig. 3). The
phospholipase C activity of HlyPC and PC were also inhibited by the
polyclonal anti-HlyPC Fab fragment but not by the Fab fragment of the
MAbs (Fig. 4). Neutralization of only the
hemolytic activity of the HlyPC molecule by the MAbs without
affecting the phospholipase C activity indicates that the epitopes
involved in the two activities are different; the functions reside in
two separate domains of the same molecule and are independent of
each other.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of various concentrations of Fab fragments of
different antibodies on the hemolytic activities of Hly (A) and HlyPC
(B). In the reaction mixtures, the amounts of HlyPC or Hly and of the
undiluted Fab fractions were in a ratio of 1:1. In subsequent reaction
mixtures, the amounts of Fab proteins varied according to the dilution.
Protein in 100 µl of undiluted Fab fractions: polyclonal, 120 µg;
3H7, 200 µg; 4C1, 125 µg.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of various concentrations of Fab fragments of
different antibodies on the phospholipase C activities of HlyPC and PC.
In the reaction mixtures, the amounts of HlyPC or PC and of the
undiluted Fab fractions were in a ratio of 1:1. In subsequent reaction
mixtures, the amounts of Fab proteins varied according to the dilution.
Protein in 100 µl of undiluted Fab fractions: polyclonal, 120 µg.
Phospholipase C from C. perfringens (Sigma) was used as a
standard. Units of enzyme activity were calculated by comparing the
release of p-nitrophenol by the sample with that of the
standard enzyme, of known enzymatic activity.
|
|
The enterotoxicity of purified HlyPC was completely neutralized in
rabbit ileal loop (4) (Table
1) and the infant mouse model
(2) (Table 2) by the Fab
fragment of the polyclonal anti-HlyPC rabbit antibody, which inhibited
in vitro both the hemolytic and enzymatic activities of the molecule.
The Fab fragment of the MAbs, which had no effect on the phospholipase
C activities of HlyPC and PC in vitro, failed to neutralize the
enterotoxic effects of the molecules in the animal models. This
indicates that the hemolytic and the enterotoxic properties of the
bifunctional molecule are unrelated to each other and that the
phospholipase C activity is responsible for the enterotoxicity. The
purified hemolysin from the PC
mutant was devoid of
enterotoxicity. These observations suggest strongly that the Hly
moiety of HlyPC alone is not diarrheagenic and that enterotoxicity is
due to PC.
The absence of correlation of the hemolytic activity of El Tor
hemolysin with its enterotoxic activity was also suggested previously
by other workers. By observing the effects of oral administration of
hlyA
ctx V. cholerae O1 El Tor strains to volunteers,
Kaper et al. (9) had indications that hemolysin was probably
not diarrhoeagenic. Alm et al. (1) had noted that the
hemolytic and enterotoxic activities of El Tor hemolysin occur at two
separate sites of the same molecule: the C-terminal end of the molecule
is associated with hemolytic activity, while the enterotoxic activity
lies in the N-terminal end. Relying on the above observation, they
further suggested that in the
hlyA
ctx strain of
V. cholerae O1 fed to volunteers by Kaper et al., the hemolytic activity was deleted but the enterotoxic activity was retained in the mutants. These observations of Kaper et al. and Alm et
al. lend strong support to our present findings that hemolysin acquires
its enterotoxic property only when it is associated with phospholipase
C as a bifunctional molecule.
The observation that the hemolysin gene, hlyA, and that for
phospholipase C occur in adjacent positions in the V. cholerae O1 and O139 chromosome in a conserved manner
(6) hints at the possibility that association of hemolysin
with phospholipase C activity as a bifunctional molecule may not be an
isolated incidence but occurs more widely than previously thought among
V. cholerae of different serogroups.
Bacterial phospholipases C have been implicated in the pathogenicity of
a number of bacteria (20). The enzyme acting on the lipid
bilayer of the mammalian cell membrane results in considerable accumulation of the end product, viz., diacylglycerol, which then stimulates the arachidonic acid cascade by more than one route. The
activation of the arachidonic acid cascade by Clostridium perfringens alpha toxin, the most studied bacterial phospholipase C, leads to production of prostaglandins which induce chloride ion
secretion in rat colonic cells via activation of chloride ion channels
(5). The nonhemolytic Bacillus cereus
phospholipase C has also been reported to activate both the arachidonic
acid cascade and prostaglandin formation in several cell types
(11). The Pseudomonas aeruginosa phospholipase C
triggers the production of thromboxanes, leukotrienes, and
prostaglandins (13). Leukotrienes C4 and
D4 are known to increase vascular permeability and to
promote exudation of fluid into the extravascular space (17,
22). Stimulation of the arachidonic acid cascade, followed by an
increase in prostaglandins leading to activation of chloride channels
and fluid secretion, as observed with other bacterial phospholipase C
enzymes, is a highly probable mechanism involved in the expression of
the enterotoxic properties of the HlyPC and PC molecules of V. cholerae O139, and it should be studied further.
 |
ACKNOWLEDGMENTS |
We thank Sujit Chowdhury and Pronob De for assistance during animal
experiments.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: National
Institute of Cholera and Enteric Diseases, Department of
Biochemistry, P-33, C.I.T. Rd., Scheme XM, Beliaghata, Calcutta 700 010, India. Phone: 91(033) 350 4598. Fax: 91(033) 350 5066. E-mail:
icmrnicd{at}ren.nic.in.
Editor: J. T. Barbieri
 |
REFERENCES |
| 1.
|
Alm, R. A.,
G. Mayrhofer,
I. Kotlarski, and P. A. Manning.
1991.
Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic.
Vaccine
9:588-594[Medline].
|
| 2.
|
Arita, M.,
T. Takeda,
T. Honda, and T. Miwatani.
1986.
Purification and characterization of Vibrio cholerae non-O1 heat-stable enterotoxin.
Infect. Immun.
52:45-49[Abstract/Free Full Text].
|
| 3.
|
Berka, R. M., and M. L. Vasil.
1982.
Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization.
J. Bacteriol.
152:239-245[Abstract/Free Full Text].
|
| 4.
|
De, S. N., and D. N. Chatterjee.
1953.
An experimental study of the mechanism of action of Vibrio cholerae on the intestinal mucous membrane.
J. Pathol. Bacteriol.
66:559-562[Medline].
|
| 5.
|
Diener, M.,
C. Egleme, and W. Rummel.
1991.
Phospholipase C induced anion secretion and its interaction with carbachol in the rat colonic mucosa.
Eur. J. Pharmacol.
200:267-276[Medline].
|
| 6.
|
Fiore, E. A.,
J. M. Michalski,
R. G. Russell,
C. L. Sears, and J. B. Kaper.
1997.
Cloning, characterization, and chromosomal mapping of a phospholipase (lecithinase) produced by Vibrio cholerae.
Infect. Immun.
65:3112-3117[Abstract].
|
| 7.
|
Honda, T., and R. A. Finkelstein.
1979.
Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios.
Infect. Immun.
26:1020-1027[Abstract/Free Full Text].
|
| 8.
|
Ichinose, Y.,
K. Yamamoto,
N. Nakasone,
M. J. Tanabe,
T. Takeda,
T. Miwatani, and M. Iwanaga.
1987.
Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae.
Infect. Immun.
55:1090-1093[Abstract/Free Full Text].
|
| 9.
|
Kaper, J. B.,
A. Fasano, and M. Trucksis.
1994.
Toxins of Vibrio cholerae, p. 145-176.
In
I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
|
| 10.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 11.
|
Levine, L.,
D. M. Xiao, and C. Little.
1988.
Increased arachidonic acid metabolites from cells in culture after treatment with phosphatidylcholine-hydrolysing phospholipase C from Bacillus cereus.
Prostaglandins
34:633-642.
|
| 12.
|
Levine, M. M.,
J. B. Kaper,
D. Herrington,
G. Losonsky,
J. G. Morris,
M. L. Clements,
R. E. Black,
B. Tall, and R. Hall.
1988.
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.
Infect. Immun.
56:161-167[Abstract/Free Full Text].
|
| 13.
|
Meyers, D. J., and R. S. Berk.
1990.
Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent.
Infect. Immun.
58:659-666[Abstract/Free Full Text].
|
| 14.
|
Nagamune, K.,
K. Yamamoto, and T. Honda.
1995.
Cloning and sequencing of a novel hemolysin gene of Vibrio cholerae.
FEMS Microbiol. Lett.
128:265-269[Medline].
|
| 15.
|
Pal, S.,
B. Guhathakurta,
D. Sasmal,
R. Mallick, and A. Datta.
1997.
Purification and characterisation of a hemolysin with phospholipase C activity from Vibrio cholerae O139.
FEMS Microbiol. Lett.
147:115-120[Medline].
|
| 16.
|
Richardson, K.,
J. Michalski, and J. B. Kaper.
1986.
Hemolysin production and cloning of two hemolysin determinants from classical Vibrio cholerae.
Infect. Immun.
54:415-420[Abstract/Free Full Text].
|
| 17.
|
Samuelsson, B.
1983.
Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.
Science
220:568-575[Abstract/Free Full Text].
|
| 18.
|
Takeda, T.,
G. B. Nair,
K. Suzuki, and Y. Shimonishi.
1990.
Production of a monoclonal antibody to Vibrio cholerae non-O1 heat-stable enterotoxin (ST) which is cross-reactive with Yersinia enterocolitica ST.
Infect. Immun.
58:2755-2759[Abstract/Free Full Text].
|
| 19.
|
Tikoo, A.,
D. V. Singh, and S. C. Sanyal.
1994.
Influence of animal passage on hemolysin and enterotoxin production in Vibrio cholerae O1 biotype El Tor strains.
J. Med. Microbiol.
40:246-251[Abstract].
|
| 20.
|
Titball, R. W.
1993.
Bacterial phospholipases C.
Microbiol. Rev.
57:347-366[Abstract/Free Full Text].
|
| 21.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from acrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 22.
|
Wadstrom, T., and R. Möllby.
1972.
Some biological properties of purified staphylococcal haemolysins.
Toxicon
10:511-519[Medline].
|
Infect Immun, August 1998, p. 3974-3977, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sun, B., Zhang, X.-H., Tang, X., Wang, S., Zhong, Y., Chen, J., Austin, B.
(2007). A Single Residue Change in Vibrio harveyi Hemolysin Results in the Loss of Phospholipase and Hemolytic Activities and Pathogenicity for Turbot (Scophthalmus maximus). J. Bacteriol.
189: 2575-2579
[Abstract]
[Full Text]